U.S. Cannabinoids Market Size, Share & Trends Analysis Report By Product Type (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG)), By Application (Inflammation, Pain Management), And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment scope
  • 1.1.2 Regional scope
  • 1.1.3 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased database:
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Competitive Insights

Chapter 3 U.S. Cannabinoids Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent market
• 3.2 Regulatory Scenario
• 3.3 Market Dynamics
  • 3.3.1 Market drivers analysis
    • 3.3.1.1 Growing number of new entrants in the market leading to expansion in product availability
    • 3.3.1.2 Increasing number of consumers opting for isolated cannabinoid products
    • 3.3.1.3 Growing number of clinical studies on the use of cannabinoids for specific applications
    • 3.3.1.4 Rising awareness about cannabinoid products and their use in health and wellness
  • 3.3.2 Market restraint analysis
    • 3.3.2.1 High price of cannabinoids-based products
    • 3.3.2.2 Expensive extraction processes for cannabinoids
    • 3.3.2.3 Absence of definite regulatory framework for minor cannabinoids
    • 3.3.2.4 Limited research is hindering the growth of the cannabinoids market
• 3.4 U.S. Cannabinoids Market Analysis Tools
  • 3.4.1 U.S. Cannabinoids Market - PESTLE Analysis
  • 3.4.2 U.S. Cannabinoids Market - PORTER'S Analysis
• 3.5 COVID Impact Analysis
• 3.6 Supply Chain Analysis
  • 3.6.1 Supply Chain Analysis - CBD Consumer Health Product
• 3.7 Product Adoption Pattern Analysis
  • 3.7.1 Cannabidiol (CBD)
  • 3.7.2 Tetrahydrocannabinol (THC)
  • 3.7.3 Cannabinol (CBN)
  • 3.7.4 Cannabidiolic Acid (CBDA)
  • 3.7.5 Others
    • 3.7.5.1 Cannabigerol (CBG)
    • 3.7.5.2 Cannabichromene (CBC)
• 3.8 Biosynthetic Cannabinoids
• 3.9 Upcoming Trends in U.S. Minor Cannabinoids Market
  • 3.9.1 Diversification Of Products:
  • 3.9.2 Increased Availability Of Minor Cannabinoids:
  • 3.9.3 More Brands Entering The Market:
  • 3.9.4 Growing Demand For Natural Remedies:
• 3.10 TAM-SAM-SOM Analysis
• 3.11 Transcript of an industry KOL
• 3.12 Key Analysis from the Primary Respondents

Chapter 4 U.S. Cannabinoids Market Segment Analysis, By Product Type, 2018 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Product Type Market Share Analysis, 2022 & 2030
• 4.3 Segment Dashboard
• 4.4 U.S. Cannabinoids Market, by Product Type, 2018 to 2030
• 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 4.5.1 Cannabidiol (CBD)
    • 4.5.1.1 Cannabidiol (CBD) market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5.2 Tetrahydrocannabinol (THC)
    • 4.5.2.1 Tetrahydrocannabinol (THC) market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5.3 Cannabinol (CBN)
    • 4.5.3.1 Cannabinol (CBN) market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5.4 Cannabigerolic Acid (CBGA)
    • 4.5.4.1 Cannabigerolic acid (CBGA) market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5.5 Cannabigerol (CBG)
    • 4.5.5.1 Cannabigerol (CBG) market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5.6 Cannabichromene (CBC)
    • 4.5.6.1 Cannabichromene (CBC) market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5.7 Tetrahydrocannabivarin (THCV)
    • 4.5.7.1 Tetrahydrocannabivarin (THCV) market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5.8 Others
    • 4.5.8.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 U.S. Cannabinoids Market Segment Analysis, By Application 2018 - 2030 (USD Million)

• 5.1 Definition and Scope
• 5.2 Application Market Share Analysis, 2022 & 2030
• 5.3 Segment Dashboard
• 5.4 U.S. Cannabinoids Market, by Application, 2018 to 2030
• 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.5.1 Inflammation
    • 5.5.1.1 Inflammation market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5.2 Pain Management
    • 5.5.2.1 Pain management market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5.3 Neurological Disorders
    • 5.5.3.1 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5.4 Cancer
    • 5.5.4.1 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5.5 Others
    • 5.5.5.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 U.S. Cannabinoids Market - Competitive Analysis

• 6.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 6.1.2 Heat map analysis
  • 6.1.3 Major Deals and Strategic Alliances Analysis
    • 6.1.3.1 Joint Ventures
    • 6.1.3.2 Licensing Agreements
    • 6.1.3.3 Product Launches
• 6.2 Company Categorization
  • 6.2.1 Innovators
  • 6.2.2 Market Leaders
• 6.3 Company Market Position Analysis
• 6.4 Company Profiles
  • 6.4.1 Mile High Labs
    • 6.4.1.1 Company overview
    • 6.4.1.2 Financial performance
    • 6.4.1.3 Product benchmarking
    • 6.4.1.4 Strategic Initiatives
  • 6.4.2 Global Cannabinoids
    • 6.4.2.1 Company overview
    • 6.4.2.2 Financial performance
    • 6.4.2.3 Product benchmarking
    • 6.4.2.4 Strategic Initiatives
  • 6.4.3 GenCanna
    • 6.4.3.1 Company overview
    • 6.4.3.2 Financial performance
    • 6.4.3.3 Product benchmarking
    • 6.4.3.4 Strategic Initiatives
  • 6.4.4 CBD Inc.
    • 6.4.4.1 Company overview
    • 6.4.4.2 Financial performance
    • 6.4.4.3 Product benchmarking
    • 6.4.4.4 Strategic Initiatives
  • 6.4.5 Precision Plant Molecules
    • 6.4.5.1 Company overview
    • 6.4.5.2 Financial performance
    • 6.4.5.3 Product benchmarking
    • 6.4.5.4 Strategic Initiatives
  • 6.4.6 Rhizo Sciences
    • 6.4.6.1 Company overview
    • 6.4.6.2 Financial performance
    • 6.4.6.3 Product benchmarking
    • 6.4.6.4 Strategic Initiatives
  • 6.4.7 LaurelCrest
    • 6.4.7.1 Company overview
    • 6.4.7.2 Financial performance
    • 6.4.7.3 Product benchmarking
    • 6.4.7.4 Strategic initiatives
  • 6.4.8 Fresh Bros Hemp Company
    • 6.4.8.1 Company overview
    • 6.4.8.2 Financial performance
    • 6.4.8.3 Product benchmarking
    • 6.4.8.4 Strategic initiatives
  • 6.4.9 BulKanna
    • 6.4.9.1 Company overview
    • 6.4.9.2 Financial performance
    • 6.4.9.3 Product benchmarking
    • 6.4.9.4 Strategic initiatives
  • 6.4.10 High-Purity Natural Products
    • 6.4.10.1 Company overview
    • 6.4.10.2 Financial performance
    • 6.4.10.3 Product benchmarking
    • 6.4.10.4 Strategic initiatives
  • 6.4.11 Zero Point Extraction, LLC
    • 6.4.11.1 Company overview
    • 6.4.11.2 Financial performance
    • 6.4.11.3 Product benchmarking
    • 6.4.11.4 Strategic initiatives

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Key companies undergoing collaboration
• Table 4 Key companies undergoing partnership
• Table 5 Key companies undergoing product launch
• Table 6 Key companies undergoing new products/services

List of Figures

• Fig. 1 U.S. cannabinoids market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2022)
• Fig. 10 Strategy framework
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 Market restraint relevance analysis (Current & future impact)
• Fig. 13 Penetration & growth prospect mapping
• Fig. 14 Porter's five forces analysis
• Fig. 15 PESTLE analysis
• Fig. 16 U.S. cannabinoids market: Product type movement analysis
• Fig. 17 U.S. cannabinoids market: Product type segment dashboard
• Fig. 18 U.S. cannabinoids market product type outlook: Key takeaways
• Fig. 19 Tetrahydrocannabinol (THC) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 Cannabidiol (CBD) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Cannabigerol (CBG) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Cannabichromene (CBC) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Cannabinol (CBN) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Tetrahydrocannabivarin (THCV) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Cannabigerolic Acid (CBGA) U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Others U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 U.S. cannabinoids market: Application movement analysis
• Fig. 28 U.S. cannabinoids market: Application segment dashboard
• Fig. 29 U.S. cannabinoids market Application outlook: Key takeaways
• Fig. 30 Inflammation U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Pain Management U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Neurological Disorders U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Cancer U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Others U.S. cannabinoids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Heat map analysis
• Fig. 36 Market differentiators